Advisory Services Network’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,578
Closed -$2K 3240
2026
Q1
$2K Buy
+1,578
New +$2.97K ﹤0.01% 4136
2025
Q4
Sell
-2,616
Closed -$7.46K 2865
2025
Q3
$7.46K Buy
+2,616
New +$8.96K ﹤0.01% 3393
2024
Q1
Sell
-228
Closed -$2.11K 2382
2023
Q4
$2.11K Buy
+228
New +$1.86K ﹤0.01% 3385
2023
Q2
Sell
-119
Closed -$1.39K 2368
2023
Q1
$1.39K Buy
119
+58
+95% +$739 ﹤0.01% 3539
2022
Q4
$648 Buy
+61
New +$589 ﹤0.01% 3695
2021
Q4
Sell
-8,371
Closed -$419K 1441
2021
Q3
$419K Sell
8,371
-263
-3% -$14.3K 0.01% 945
2021
Q2
$479K Sell
8,634
-658
-7% -$35.1K 0.02% 900
2021
Q1
$435K Buy
9,292
+495
+6% +$24K 0.02% 887
2020
Q4
$383K Buy
+8,797
New +$325K 0.02% 848

Other funds holding HCAT

Advisory Services Network's HCAT Position: Q2 2026 in Review

Advisory Services Network sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 1,578 shares — an estimated $2K sold.

Advisory Services Network first reported a position in HCAT in Q4 2020 and held it in 9 quarters. The position peaked at $479K in Q2 2021. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Advisory Services Network reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 1,578 Health Catalyst shares in Q2 2026, an estimated $2K.
  • Advisory Services Network first reported a position in Health Catalyst in Q4 2020 and held it in 9 quarters.
  • Advisory Services Network's Health Catalyst position peaked at $479K in Q2 2021.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.